AMENDED AND RESTATED PROMISSORY NOTE AND SECURITY AGREEMENTPromissory Note and Security Agreement • September 30th, 2020 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
This Note amends and restates in its entirety (i) that certain Promissory Note and Security Agreement dated July 21, 2020 (as the same has been amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Original July 21 Note”), made by Debtor in favor of the Holder in the original principal amount of Seven Hundred and Fifty Thousand and 00/100 Dollars ($750,000) and for which, as of September 25, 2020 (the “Restatement Effective Date”), the principal amount (excluding any unpaid interest not yet accreted to principal or paid in cash) outstanding is $770,750 immediately prior to being amended and restated hereby, and (ii) that certain Promissory Note and Security Agreement dated July 29, 2020 (as the same has been amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Original July 29 Note”, and together with the Original July 21 Note, the “Original Notes”), made by Debtor in favor of the
CONSULTING AGREEMENTConsulting Agreement • September 30th, 2020 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
This Agreement is made and entered into effective as of the 25th day of September, 2020, by and between ProPhase Labs, Inc., a Delaware corporation (the “Company”), and Predictive Laboratories, Inc., a Utah corporation (the “Consultant”).
